CLINICAL_TRIALS
trial_result
· 2023-08-21
Clinical Trial Update: Evaluation of Safety and Tolerability of BI 894416 in Patients With Mild Asthma [Phase 1]
Summary
Phase 1 trial updating safety and tolerability of BI 894416 in adults with mild asthma.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Boehringer Ingelheim | Conditions: Asthma | Phase 1 | Status: COMPLETED | Results posted: 2023-08-21